Last update:

Oncology & Cancer news

Oncology & Cancer

Custom-designed protein receptors help T cells target solid tumors more effectively

Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, especially those equipped with chimeric antigen receptors (CAR-T cells), have revolutionized cancer ...

Oncology & Cancer

Making cancer vaccines more personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that contain features of good candidates ...

Oncology & Cancer

Outdoor air pollution linked to higher incidence of breast cancer

Women living in parts of the United States with lower air quality, especially neighborhoods with heavy emissions from motor vehicles, are more likely to develop breast cancer, according to a multiyear analysis involving more ...

Oncology & Cancer

Scientists uncover new driver of ovarian cancer spread

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly improve the outlook for women diagnosed with this aggressive disease.

Oncology & Cancer

Why fasting won't cleanse your body—or beat cancer

Every few months, a new "miracle cure" for cancer trends on social media. From superfoods and supplements to extreme diets, the promises are always bold—and almost always misleading. The latest claim suggests that a 21-day ...

Oncology & Cancer

Living tumor-on-a-chip exposes how cancers block immune attacks

For a little over two decades, chimeric antigen receptor (CAR) T cell therapy has emerged as a powerful new way to treat cancer. By extracting patients' T cells, re-engineering them to recognize tumor antigens, and infusing ...

Oncology & Cancer

Modern radiotherapy delivers higher doses with fewer sessions

New research from the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) demonstrates the accuracy of modern radiotherapy techniques used to treat cancer. The study is published in the Journal of Applied ...

Oncology & Cancer

Cold plasma penetrates deep into tissue to fight cancer

Researchers at the Leibniz Institute for Plasma Science and Technology (INP) have collaborated with partners at Greifswald University Hospital and University Medical Center Rostock to demonstrate that cold plasma can effectively ...

Oncology & Cancer

How lymphoma rewires the human genome

Translocations are chromosomal "cut and paste" errors that drive many lymphomas, a type of blood cancer and the sixth most common form of cancer overall. This includes mantle cell lymphoma, a rare but aggressive subtype diagnosed ...

Oncology & Cancer

Genetic study suggests ways to catch blood cancer earlier

As we age, our cells replicate, and the DNA in these cells can acquire mistakes—or mutations—every time the sequence is copied. Most newly acquired mutations are harmless, but some can tip the balance toward cancer development ...

Oncology & Cancer

New study maps out the timeline of DNA damage for multiple myeloma

A new study focused on multiple myeloma, the second most common blood cancer, may lead to better ways to group patients by the state of their DNA and define new subtypes of disease to better predict treatment strategies and ...

Oncology & Cancer

Blocking brain damage may slow glioblastoma growth

Blocking brain damage triggered by a glioblastoma, an aggressive brain cancer, may slow the growth of the cancer and allow the brain to keep working better for longer, according to a new study led by UCL (University College ...